Mechanistic Characterization and Molecular Modeling of Hepatitis B Virus Polymerase Resistance to Entecavir

Ann W. Walsh, David R. Langley, Richard J. Colonno et al. · 2010

Read Mechanistic Characterization and Molecular Modeling of Hepatitis B Virus Polymerase Resistance to Entecavir by Ann W. Walsh, David R. Langley, Richard J. Colonno et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009195.txt.

Description

Ann Walsh, David Langley, Richard Colonno, and co-authors published this virology study in PLOS ONE in 2010. It examines entecavir, a drug used against hepatitis B virus. Entecavir blocks the viral polymerase, the enzyme the virus uses to copy its DNA. In clinics, the virus rarely learns to resist the drug.

The team combined lab experiments with computer modeling of the polymerase. They worked out, step by step, how entecavir stops DNA copying with delayed chain termination. They also examined what changes the virus would need to escape the drug. Multiple required changes help explain why resistance stays rare, which supports entecavir as a durable treatment.

Catalog record

CREATORAnn W. Walsh, David R. Langley, Richard J. Colonno et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE61 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009195

Browse the full library · About the Tower of Babel